New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 27, 2013
07:17 EDTPACB, ILMN, FLDM, LIFELeerink to host a tour
Genomics Lab Tour consists of a tour of the Kansas University Medical Center's Genomics Lab and discusses the demand for DNA sequencing technologies, interest in new products, impact of funding constraints and DNA sequencing in the clinic. Relevant covered companies include Illumina, Life Technologies, Fluidigm and Pacific Biosciences. The tour is in Kansas City, Kansas and starts at 2 pm on March 27.
News For ILMN;LIFE;FLDM;PACB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 26, 2015
09:44 EDTILMNIllumina participates in a conference call with JPMorgan
Subscribe for More Information
May 22, 2015
16:28 EDTLIFEPolaris Venture Partners reports 8.2% stake in aTyr Pharma
Subscribe for More Information
May 19, 2015
09:18 EDTILMNBofA/Merrill life sciences analysts hold an analyst/industry conference call
Analysts, along with Nancy J. Kelley, a nationally recognized executive and lawyer who has championed the field of Synthetic/Engineering Biology in the U.S., discuss what Synthetic Biology is and whether it will disrupt the Healthcare landscape and how Synthetic Biologic-based products would be regulated on an Analyst/Industry conference call to be held on May 19 at 2 pm.
May 18, 2015
16:07 EDTILMNIllumina files new patent infringement suit against Roche unit
Subscribe for More Information
06:38 EDTFLDMFluidigm shares offer attractive entry point, says Leerink
Leerink believes the current share of Fluidigm represents an attractive entry point ahead of the company's new product launches. The firm thinks Fluidigm is well positioned to benefit from the growth in single cell analysis. It keeps an Outperform rating on the name with a $45 price target.
May 15, 2015
16:22 EDTLIFESofinnova Venture Partners IX reports 8.3% stake in aTyr Pharma
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use